| A6730 | Akt 1/2 inhibitor |
| AD | Alzheimer’s disease |
| Aβ | Amyloid-β |
| Akt | Protein kinase B |
| ApoE4 | Apolipoprotein E |
| APP | Amyloid precursor protein |
| Axl | Axl receptor tyrosine kinase |
| Bad | Bcl-2-associated death promoter protein, tyros3, Axl and Mer (TAM) family |
| C99 | C-terminal 99 residues of APP |
| β-CTF | C-terminal 99-residue fragment of APP |
| β-CTF/C6 | C6 cell line-containing β-CTF gene |
| ERK1/2 | Extracellular signal-regulated protein kinases 1 and 2 |
| Gas6 | Growth arrest-specific protein 6 |
| HEK293 | Human embryonic kidney 293 |
| c-JNK | C-Jun N-terminal kinase |
| LY294002 | PI3K inhibitor |
| MAPK | Mitogen-activated protein kinase |
| MK4 | Menaquinone-4 |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| p38-SAPK | Stress-activated protein kinase p38 |
| PD98059 | Extracellular signal-regulated protein kinases 1 and 2 (ERK) inhibitor |
| PI3K | Phosphatidylinositol 3-kinase |
| R428 | Axl inhibitor |
| ROS | Reactive oxygen species |
| SB202190 | Stress-activated protein kinase p38 (p38-SAPK) inhibitor |
| SN50 | NF-κB inhibitor |
| SP600125 | JNK inhibitor |
| VKD | Vitamin K-dependent |